[HTML][HTML] Cancer stem cells—origins and biomarkers: perspectives for targeted personalized therapies

L Walcher, AK Kistenmacher, H Suo, R Kitte… - Frontiers in …, 2020 - frontiersin.org
The use of biomarkers in diagnosis, therapy and prognosis has gained increasing interest
over the last decades. In particular, the analysis of biomarkers in cancer patients within the …

The multifaceted role of autophagy in cancer

RC Russell, KL Guan - The EMBO journal, 2022 - embopress.org
Autophagy is a cellular degradative pathway that plays diverse roles in maintaining cellular
homeostasis. Cellular stress caused by starvation, organelle damage, or proteotoxic …

[HTML][HTML] The roles of autophagy in cancer

CW Yun, SH Lee - International journal of molecular sciences, 2018 - mdpi.com
Autophagy is an intracellular degradative process that occurs under several stressful
conditions, including organelle damage, the presence of abnormal proteins, and nutrient …

[HTML][HTML] Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications

F Nazio, M Bordi, V Cianfanelli, F Locatelli… - Cell Death & …, 2019 - nature.com
Autophagy and mitophagy act in cancer as bimodal processes, whose differential functions
strictly depend on cancer ontogenesis, progression, and type. For instance, they can act to …

Autophagy, cancer stem cells and drug resistance

AG Smith, KF Macleod - The Journal of pathology, 2019 - Wiley Online Library
Autophagy is a cellular survival mechanism that is induced by cancer therapy, among other
stresses, and frequently contributes to cancer cell survival during long periods of dormancy …

Recent insights into the function of autophagy in cancer

R Amaravadi, AC Kimmelman, E White - Genes & development, 2016 - genesdev.cshlp.org
Macroautophagy (referred to here as autophagy) is induced by starvation to capture and
degrade intracellular proteins and organelles in lysosomes, which recycles intracellular …

[HTML][HTML] Breast cancer: multiple subtypes within a tumor?

SK Yeo, JL Guan - Trends in cancer, 2017 - cell.com
Breast cancer is a heterogeneous disease, and stratification of tumors is paramount to
achieve better clinical outcomes. While it is common to stratify and treat breast tumors as a …

[HTML][HTML] Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges

R Butti, S Das, VP Gunasekaran, AS Yadav, D Kumar… - Molecular cancer, 2018 - Springer
Breast cancer is a multifactorial disease and driven by aberrant regulation of cell signaling
pathways due to the acquisition of genetic and epigenetic changes. An array of growth …

[HTML][HTML] Triple-negative breast cancer: current understanding and future therapeutic breakthrough targeting cancer stemness

KL Lee, YC Kuo, YS Ho, YH Huang - Cancers, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen
receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor …

[HTML][HTML] Autophagic regulation of p62 is critical for cancer therapy

MA Islam, MA Sooro, P Zhang - International journal of molecular …, 2018 - mdpi.com
Sequestosome1 (p62/SQSTM 1) is a multidomain protein that interacts with the autophagy
machinery as a key adaptor of target cargo. It interacts with phagophores through the LC3 …